Respiratory Bacterial Culture Sampling in Expectorating and Non-expectorating Patients With Cystic Fibrosis
Purpose: Different respiratory sampling methods exist to identify lower airway pathogens in patients with cystic fibrosis (CF), of which bronchoalveolar lavage (BAL), and expectorated sputum are considered the “gold standard.” Because BAL cannot be repeated limitless, the diagnosis of lower respirat...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-12-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fped.2018.00403/full |
_version_ | 1828769069383286784 |
---|---|
author | Hanneke Eyns Hanneke Eyns Hanneke Eyns Denis Piérard Elke De Wachter Leo Eeckhout Peter Vaes Peter Vaes Anne Malfroot |
author_facet | Hanneke Eyns Hanneke Eyns Hanneke Eyns Denis Piérard Elke De Wachter Leo Eeckhout Peter Vaes Peter Vaes Anne Malfroot |
author_sort | Hanneke Eyns |
collection | DOAJ |
description | Purpose: Different respiratory sampling methods exist to identify lower airway pathogens in patients with cystic fibrosis (CF), of which bronchoalveolar lavage (BAL), and expectorated sputum are considered the “gold standard.” Because BAL cannot be repeated limitless, the diagnosis of lower respiratory tract infections in non-expectorating patients is challenging. Other sampling techniques are nasal swab, cough swab, and induced sputum. The purpose of this study (NCT02363764) was to compare concordance between the microbiological yield of nasal swab, cough swab, and expectorated sputum in expectorating patients; nasal swab, cough swab, and induced sputum in non-expectorating patients; nasal swab, cough swab, induced sputum, and BAL in patients requiring bronchoscopy (“BAL-group”); and to determine the clinical value of cough swab in non-expectorating patients with CF.Methods: Microbiological yield detected by these different sampling techniques was compared between and within 105 expectorating patients, 30 non-expectorating patients and BAL-group (n = 39) in a single CF clinic. Specificity, sensitivity, positive (PPV), and negative (NPV) predictive values were calculated.Results: Overall low sensitivity (6.3–58.0%) and wide-ranging predictive values (0.0–100.0%) indicated that nasal swab was not appropriate to detect lower airway pathogens [Pseudomonas aeruginosa (Pa), Staphylococcus aureus (Sa), and Haemophilus influenzae (Hi)] in all three patient groups. Microbiological yield, specificity, sensitivity, PPV, and NPV of cough swab and induced sputum were largely similar in non-expectorating patients and in BAL-group (except sensitivity (0.0%) of induced sputum for Hi in BAL-group). Calculations for Pa and Hi could not be performed for non-expectorating patients because of low prevalence (n = 2 and n = 3, respectively). In expectorating patients, concordance was found between cough swab and expectorated sputum, except for Hi (sensitivity of 40.0%).Conclusion: Our findings suggest that cough swab might be helpful in detecting the presence of some typical CF pathogens in the lower airways of clinically stable patients with CF. However, in symptomatic patients, who are unable to expectorate and who have a negative cough swab and induced sample, BAL should be performed as it currently remains the “gold standard.” |
first_indexed | 2024-12-11T13:41:12Z |
format | Article |
id | doaj.art-ce397749bb8140c492b71c9920fefdca |
institution | Directory Open Access Journal |
issn | 2296-2360 |
language | English |
last_indexed | 2024-12-11T13:41:12Z |
publishDate | 2018-12-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Pediatrics |
spelling | doaj.art-ce397749bb8140c492b71c9920fefdca2022-12-22T01:04:46ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602018-12-01610.3389/fped.2018.00403380003Respiratory Bacterial Culture Sampling in Expectorating and Non-expectorating Patients With Cystic FibrosisHanneke Eyns0Hanneke Eyns1Hanneke Eyns2Denis Piérard3Elke De Wachter4Leo Eeckhout5Peter Vaes6Peter Vaes7Anne Malfroot8Department of Pediatrics, Pediatric Pulmonology and Pediatric Infectious Diseases, Cystic Fibrosis Clinic, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, BelgiumDepartment of Physical Medicine and Physiotherapy, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, BelgiumDepartment of Physiotherapy, Human Physiology and Anatomy, Faculty of Physical Education and Physiotherapy, Vrije Universiteit Brussel, Brussels, BelgiumDepartment of Microbiology and Infection Control, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, BelgiumDepartment of Pediatrics, Pediatric Pulmonology and Pediatric Infectious Diseases, Cystic Fibrosis Clinic, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, BelgiumDepartment of Microbiology and Infection Control, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, BelgiumDepartment of Physical Medicine and Physiotherapy, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, BelgiumDepartment of Physiotherapy, Human Physiology and Anatomy, Faculty of Physical Education and Physiotherapy, Vrije Universiteit Brussel, Brussels, BelgiumDepartment of Pediatrics, Pediatric Pulmonology and Pediatric Infectious Diseases, Cystic Fibrosis Clinic, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, BelgiumPurpose: Different respiratory sampling methods exist to identify lower airway pathogens in patients with cystic fibrosis (CF), of which bronchoalveolar lavage (BAL), and expectorated sputum are considered the “gold standard.” Because BAL cannot be repeated limitless, the diagnosis of lower respiratory tract infections in non-expectorating patients is challenging. Other sampling techniques are nasal swab, cough swab, and induced sputum. The purpose of this study (NCT02363764) was to compare concordance between the microbiological yield of nasal swab, cough swab, and expectorated sputum in expectorating patients; nasal swab, cough swab, and induced sputum in non-expectorating patients; nasal swab, cough swab, induced sputum, and BAL in patients requiring bronchoscopy (“BAL-group”); and to determine the clinical value of cough swab in non-expectorating patients with CF.Methods: Microbiological yield detected by these different sampling techniques was compared between and within 105 expectorating patients, 30 non-expectorating patients and BAL-group (n = 39) in a single CF clinic. Specificity, sensitivity, positive (PPV), and negative (NPV) predictive values were calculated.Results: Overall low sensitivity (6.3–58.0%) and wide-ranging predictive values (0.0–100.0%) indicated that nasal swab was not appropriate to detect lower airway pathogens [Pseudomonas aeruginosa (Pa), Staphylococcus aureus (Sa), and Haemophilus influenzae (Hi)] in all three patient groups. Microbiological yield, specificity, sensitivity, PPV, and NPV of cough swab and induced sputum were largely similar in non-expectorating patients and in BAL-group (except sensitivity (0.0%) of induced sputum for Hi in BAL-group). Calculations for Pa and Hi could not be performed for non-expectorating patients because of low prevalence (n = 2 and n = 3, respectively). In expectorating patients, concordance was found between cough swab and expectorated sputum, except for Hi (sensitivity of 40.0%).Conclusion: Our findings suggest that cough swab might be helpful in detecting the presence of some typical CF pathogens in the lower airways of clinically stable patients with CF. However, in symptomatic patients, who are unable to expectorate and who have a negative cough swab and induced sample, BAL should be performed as it currently remains the “gold standard.”https://www.frontiersin.org/article/10.3389/fped.2018.00403/fullcystic fibrosisrespiratory samplescough swabsputumbronchoalveolar lavage (BAL) |
spellingShingle | Hanneke Eyns Hanneke Eyns Hanneke Eyns Denis Piérard Elke De Wachter Leo Eeckhout Peter Vaes Peter Vaes Anne Malfroot Respiratory Bacterial Culture Sampling in Expectorating and Non-expectorating Patients With Cystic Fibrosis Frontiers in Pediatrics cystic fibrosis respiratory samples cough swab sputum bronchoalveolar lavage (BAL) |
title | Respiratory Bacterial Culture Sampling in Expectorating and Non-expectorating Patients With Cystic Fibrosis |
title_full | Respiratory Bacterial Culture Sampling in Expectorating and Non-expectorating Patients With Cystic Fibrosis |
title_fullStr | Respiratory Bacterial Culture Sampling in Expectorating and Non-expectorating Patients With Cystic Fibrosis |
title_full_unstemmed | Respiratory Bacterial Culture Sampling in Expectorating and Non-expectorating Patients With Cystic Fibrosis |
title_short | Respiratory Bacterial Culture Sampling in Expectorating and Non-expectorating Patients With Cystic Fibrosis |
title_sort | respiratory bacterial culture sampling in expectorating and non expectorating patients with cystic fibrosis |
topic | cystic fibrosis respiratory samples cough swab sputum bronchoalveolar lavage (BAL) |
url | https://www.frontiersin.org/article/10.3389/fped.2018.00403/full |
work_keys_str_mv | AT hannekeeyns respiratorybacterialculturesamplinginexpectoratingandnonexpectoratingpatientswithcysticfibrosis AT hannekeeyns respiratorybacterialculturesamplinginexpectoratingandnonexpectoratingpatientswithcysticfibrosis AT hannekeeyns respiratorybacterialculturesamplinginexpectoratingandnonexpectoratingpatientswithcysticfibrosis AT denispierard respiratorybacterialculturesamplinginexpectoratingandnonexpectoratingpatientswithcysticfibrosis AT elkedewachter respiratorybacterialculturesamplinginexpectoratingandnonexpectoratingpatientswithcysticfibrosis AT leoeeckhout respiratorybacterialculturesamplinginexpectoratingandnonexpectoratingpatientswithcysticfibrosis AT petervaes respiratorybacterialculturesamplinginexpectoratingandnonexpectoratingpatientswithcysticfibrosis AT petervaes respiratorybacterialculturesamplinginexpectoratingandnonexpectoratingpatientswithcysticfibrosis AT annemalfroot respiratorybacterialculturesamplinginexpectoratingandnonexpectoratingpatientswithcysticfibrosis |